文献速递腹部胸部泌尿生殖CT

肺癌患者高密度肾上腺病变:双期CT(平扫与1分钟增强)可可靠预测良性病变

Hyperattenuating adrenal lesions in lung cancer: biphasic CT with unenhanced and 1-min enhanced images reliably predicts benign lesions.
PubMed 文献 · Eur Radiol · 2021-01-18

这项回顾性研究纳入239例肺癌伴高密度(>10 HU)肾上腺病变患者,采用平扫及1分钟、15分钟增强肾上腺CT。以病理或随访CT稳定≥6个月为良性参考标准,比较三期的绝对/相对廓清率(标准1)与双期的增强比>3及百分比流入>200%(标准2)诊断良性的效能,两标准AUC无显著差异,双期CT可可靠鉴别良恶性。

要点

  • 双期CT标准(增强比>3且百分比流入>200%)诊断良性肾上腺病变AUC为0.886(读者1)和0.814(读者2)。
  • 双期CT标准与三期的廓清率标准AUC无显著差异(读者1 P=0.566;读者2 P=0.955)。
  • 双期CT两标准读者间加权kappa分别为0.725与0.736,一致性良好。

核心结论

  • 双期CT(平扫与1分钟增强)可可靠鉴别肺癌患者的高密度肾上腺病变的良恶性。

研究设计与样本

  • 回顾性研究纳入239例肺癌患者,均因高密度(>10 HU)肾上腺病变行肾上腺CT。
  • 肾上腺CT包括平扫、1分钟增强和15分钟增强三期图像。
  • 良性参考标准为组织学确认或随访CT稳定≥6个月。
  • 由两名独立读者分别分析三期的绝对廓清率(APW)或相对廓清率(RPW),以及双期的增强比(ER)或百分比流入(PWI)。

诊断标准与关键数值

  • 标准1(三期):良性判定为(a)APW≥60%或(b)RPW≥40%。
  • 标准2(双期):良性判定为(a)ER>3且(b)PWI>200%。
  • 标准1的AUC:读者1为0.872(95%CI 0.822-0.911),读者2为0.816(95%CI 0.761-0.863);准确率:读者1为87.9%(210/239),读者2为81.2%(194/239)。
  • 标准2的AUC:读者1为0.886(95%CI 0.838-0.923),读者2为0.814(95%CI 0.759-0.862);准确率:读者1为86.2%(206/239),读者2为80.3%(192/239)。
  • 两标准AUC比较:读者1 P=0.566,读者2 P=0.955;准确率比较:读者1 P=0.479,读者2 P=0.763。

临床应用与阅片要点

  • 对肺癌患者的高密度(>10 HU)肾上腺病变,可用平扫与1分钟增强的双期CT计算增强比和百分比流入来预测良性。
  • 双期CT标准(ER>3且PWI>200%)与三期廓清率标准的诊断效能无显著差异,阅片时可作为替代方案。
  • 原文指出双期CT的流入特征有助于预测肺癌患者的良性肾上腺病变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate usefulness of biphasic computed tomography (CT) in characterizing hyperattenuating adrenal lesions in lung cancer.

METHODS: This retrospective study included 239 patients with lung cancer who underwent adrenal CT for hyperattenuating (> 10 Hounsfield unit) adrenal lesions. Adrenal CT comprised unenhanced and 1-min and 15-min enhanced images. We dichotomized adrenal lesions depending on benign or metastatic lesions. Reference standard for benignity was histologic confirmation or ≥ 6-month stability on follow-up CT. Two independent readers analyzed absolute (APW) or relative percentage wash-out (RPW) using triphasic CT, and enhancement ratio (ER) or percentage wash-in (PWI) using biphasic CT (i.e., unenhanced and 1-min enhanced CT). Criteria for benignity were as follows: criteria 1, (a) APW ≥ 60% or (b) RPW ≥ 40%, and criteria 2, (a) ER > 3 and (b) PWI > 200%. We analyzed area under the curve (AUC) and accuracy for benignity, and inter-reader agreement.

RESULTS: Proportion of benign adrenal lesion was 71.1% (170/239). For criteria 1 and 2, AUCs were 0.872 (95% confidence interval [CI], 0.822-0.911) and 0.886 (95% CI, 0.838-0.923), respectively, for reader 1 (p = 0.566) and 0.816 (95% CI, 0.761-0.863) and 0.814 (95% CI, 0.759-0.862), respectively, for reader 2 (p = 0.955), and accuracies were 87.9% (210/239) and 86.2% (206/239), respectively, for reader 1 (p = 0.479) and 81.2% (194/239) and 80.3% (192/239), respectively, for reader 2 (p = 0.763). Weighted kappa was 0.725 (95% CI, 0.634-0.816) for criteria 1 and 0.736 (95% CI, 0.649-0.824) for criteria 2.

CONCLUSION: Biphasic CT can reliably characterize hyperattenuating adrenal lesions in patients with lung cancer.

KEY POINTS: • Criteria from biphasic computed tomography (CT) for diagnosing benign adrenal lesions were enhancement ratio of > 3 and percentage wash-in of > 200%. • In the analysis by two independent readers, area under the curve between criteria 1 and 2 was not significantly different (0.872 and 0.886 for reader 1; 0.816 and 0.814, for reader 2; p > 0.05 for each comparison). • Wash-in characteristics from biphasic CT are helpful to predict benign adrenal lesions in lung cancer.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lee HY, Oh YL, Park SY, et al. Hyperattenuating adrenal lesions in lung cancer: biphasic CT with unenhanced and 1-min enhanced images reliably predicts benign lesions. Eur Radiol. 2021. PMID: 33459853. doi:10.1007/s00330-020-07648-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。